You are here:
Publication details
Validita a prediktivní hodnota skríningových testů u prediabetické a časné diabetické polyneuropatie
Title in English | Validity and predictive value of screening tests in prediabetic and early diabetic polyneuropathy |
---|---|
Authors | |
Year of publication | 2012 |
Type | Article in Periodical |
Magazine / Source | Česká a slovenská neurologie a neurochirurgie |
MU Faculty or unit | |
Citation | |
Field | Neurology, neurosurgery, neurosciences |
Keywords | prediabetes; type 2 diabetes mellitus; small-fiber neuropathy; large-fiber neuropathy; early diabetic neuropathy |
Description | Aim: To confirm the validity and predictive value of selected screening tests for neuropathy The Michigan Neuropathy Screening Instrument (MNSI) and The Utah Early Neuropathy Scale (UENS), and a screening test for detection of neuropathic pain - DN4 - in a population of patients with prediabetes and early type 2 diabetes mellitus (preDM/eDM2). Conclusions: DN4 is able to discriminate patients with and without DPNP; the recommended cut-off values, however, provide high specificity but low sensitivity (i.e. attributes typical for a confirmatory, not a screening test). MNSI I discriminated patients with clinically-based SFN, although not when the recommended cut-off value of >7 points was used. Both MNSI II and UENS reliably discriminated preDM/eDM2 patients with and without LFN while only UENS discriminated patients with and without clinically-based SEN. Neither test was useful for detection of laboratory-based SFN. |
Related projects: |